News und Analysen

Investors who watch AT&T (NYSE: T) closely know that it has spent the last two years atoning for a costly mistake. It not only strayed from its core service offerings but also overpaid to enter the

On the surface, Pfizer (NYSE: PFE) had some good news to report on Thursday. But investors viewed the positive as a negative, in light of its timing. This wasn't helped by an analyst's price-target

Image source: The Motley Fool.

Medtronic (NYSE: MDT)Q4 2023 Earnings CallMay 25, 2023, 8:00 a.m. ET

Ryan Weispfenning

Continue reading

Source Fool.com

Wall Street has high hopes for certain stocks over the coming 12 months. Two of them are biotech companies that took center stage during earlier days of the pandemic. I'm talking about Novavax

Pfizer (NYSE: PFE) has been a losing play for investors over the past 12 months. To wit: The drugmaker's stock has fallen by a whopping 28.8% over this period. Part of that decline has been driven

Shares of the medical device maker Medtronic (NYSE: MDT) were down by 5% on heavy volume as of 10:53 a.m. ET Thursday. The big loss came after the company reported its 2023 fourth-quarter results

Dividend Kings have excellent track records for dividend growth, and are often seen as some of the safest income investments to own. Two dividend growth stocks that may look tempting and that

A good way to diversify your portfolio is to invest in companies in different industries. And if you want to minimize your risk, a good option is to consider investing in industry leaders. Their

Telecom giant AT&T (NYSE: T) has a very simple story now that it's shed its ambitions to become a media conglomerate. The core business is wireless, which will grow slowly at best. The secondary

Shares of Organogenesis (NASDAQ: ORGO) were up 15.4% Wednesday afternoon after being up as much as 21.2% Wednesday morning. The healthcare company sells advanced wound care products for surgical and

Shares of Sarepta Therapeutics (NASDAQ: SRPT), which focuses on genetic treatments for rare diseases, were down 11.5% Wednesday afternoon after the Food and Drug Administration (FDA) pushed back its

Shares of the clinical-stage drugmaker Madrigal Pharmaceuticals (NASDAQ: MDGL) were up by 6.2% on elevated volume as of 12:16 p.m. ET Wednesday. The biotech appears to be benefiting from two key

Shares of Agilent Technologies (NYSE: A) were sinking 7.9% lower as of 11:34 a.m. ET on Wednesday. The decline came after the life sciences company announced its fiscal 2023 second-quarter results

There are reasons to be wary of the stock market right now. Chief among them is the fact that the economy continues to be somewhat uncertain, making it difficult to predict how things will develop

It's been tough to be an investor of late. Stocks are dishing out plenty of drama (and volatility) this year, making it uncomfortable to stick with them.

If your time frame truly is "forever,"

Medtronic (NYSE: MDT) is on a roll. Its shares have soared close to 15% year to date, easily outperforming the S&P 500.

But is Medtronic a stock to consider buying right now? Here are the bull and

Healthcare stocks make great additions to your portfolio at any time. You generally can count on the biggest players for a certain stability in earnings. That's because, in good times and in bad

The Federal Trade Commission (FTC) has been taking a much more adversarial approach to mergers and acquisitions lately. For instance, it recently said it plans to block the pending deal between

Shares of Integra LifeSciences (NASDAQ: IART) were crashing on Tuesday, with the stock falling 20.7% as of 3:39 p.m. ET. The steep decline came after the company revealed in a regulatory filing that